West Pharmaceutical Services (WST) Shares Outstanding (2009 - 2026)

West Pharmaceutical Services has disclosed Shares Outstanding across 17 years of filings, most recently posting $75.3 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $75.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.3 million (changed 0.0% YoY), and the FY2025 annual result was $75.3 million, changed 0.0% from the prior year.
• Shares Outstanding came in at $75.3 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $75.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $75.3 million in Q1 2022 to a low of $72.0 million in Q4 2025.
• The 5-year median for Shares Outstanding is $75.3 million (2022), against an average of $75.1 million.
• Peak annual rise in Shares Outstanding reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• West Pharmaceutical Services' Shares Outstanding stood at $75.3 million in 2022, then changed by 0.0% to $75.3 million in 2023, then changed by 0.0% to $75.3 million in 2024, then changed by 0.0% to $75.3 million in 2025, then changed by 0.0% to $75.3 million in 2026.
• The last three Shares Outstanding figures came in at $75.3 million (Q1 2026), $75.3 million (Q4 2025), and $75.3 million (Q3 2025), per Business Quant data.